COMMUNIQUÉS West-GlobeNewswire
 
      -   
  Amwell® to report third quarter 2025 operating results; company leaders to attend upcoming investor conferences27/10/2025
-   
  Elixir Medical annonce de nouveaux résultats cliniques significatifs pour le DynamX® Bioadaptor, démontrant une réduction de près de 50 % des taux d’événements coronariens par rapport à la norme actuelle de soins ICP27/10/2025
-   
  Elixir Medical Announces Significant Late Breaking Clinical Results for DynamX® Bioadaptor Demonstrating Nearly 50% Reduction in Coronary Event Rates vs. Current PCI Standard of Care27/10/2025
-   
  Aurora Spine Launches New Biologics Portfolio27/10/2025
-   
  Anteris Technologies Announces First Patients Treated in DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)27/10/2025
-   
  Protext Mobility, Inc. (OTC: TXTM) Ignites Next Phase of Growth with Investor Relations Presentation Initiative — Setting the Stage for a New Era of Transparency and Acceleration27/10/2025
-   
  LifeLabs Care Packages Bring Comfort to Children with Cancer at POGO Satellite Clinics27/10/2025
-   
  Chiffre d'affaires au 30 septembre 202527/10/2025
-   
  Revenue for the nine months ended 30 September 202527/10/2025
-   
  Health Canada Approval of Lecanemab Offers New Hope for Ontarians Living with Alzheimer’s Disease27/10/2025
-   
  Fungushead Launches Veteran ‘Angel’s Wing Scholarship’ and Reaffirms Microscopy-Only Standards as California Accelerates Psychedelic Research (AB 1103)27/10/2025
-   
  Axis Integrated Mental Health Acquires Best Mind to Combat Colorado’s Mental Health Crisis27/10/2025
-   
  Arcutis to Present at Upcoming Investor Conferences27/10/2025
-   
  Prenetics Announces Oversubscribed Approximately $48 Million Equity Offering with Potential for $216 Million in Total Proceeds to Fuel IM8’s Global Expansion and Bitcoin Treasury Strategy27/10/2025
-   
  MAIA Biotechnology Presents Trial in Progress Poster at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics27/10/2025
-   
  Smith+Nephew comparative study1 shows PICO◊ sNPWT (-80 mmHg) delivers superior performance in relation to wound dehiscence and reduces healthcare costs across cardiovascular and orthopedic surgery versus PrevenaTM -125 mmHg sNPWT27/10/2025
-   
  Valneva fera des présentations et rencontrera les investisseurs lors de conférences aux États-Unis et en Europe27/10/2025
-   
  Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences27/10/2025
-   
  Hapbee Appoints New Leaders to Accelerate Women’s Wellness Through Frequency Healing Technology27/10/2025
Pages